AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4

Sitawow M 50/500 Tablet

Prescription Icon
Prescription Required

Marketer

Medicamen Lifesciences Pvt Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitawow M 50/500 Tablet

Diabex Duo 50/500 tablets combine two medications to manage elevated blood glucose in type 2 diabetes patients. This dual action helps prevent serious diabetic complications like vision loss and kidney disease, potentially lowering heart attack and stroke risks. Diabex Duo 50/500 may be used independently or with other diabetes treatments. Optimal results require a healthy diet and regular physical activity. Dosage is personalized based on your health status, blood sugar readings, and current medications. Taking it with food minimizes stomach upset. Consistent daily dosing at the same time maximizes effectiveness; discontinue only under your physician's guidance. Adherence to your prescribed diet and exercise plan is crucial. Lifestyle choices significantly impact diabetes control. Common side effects include nausea, vomiting, diarrhea, stomach discomfort, headache, and sore throat. Low blood sugar (hypoglycemia) is possible, especially with concurrent use of insulin or sulfonylureas; learn to identify and manage this. This medication isn't for everyone. Inform your doctor about prior kidney, liver, or heart conditions, pancreatic issues, or significant alcohol consumption before starting. Pregnant or breastfeeding individuals should seek medical advice. Other medications may interact with Diabex Duo 50/500; disclose all medications to ensure safety. Alcohol should be limited due to its blood sugar-lowering effect. Your doctor will monitor kidney function and blood glucose levels throughout treatment.

Primary Ingredients of Sitawow M 50/500 Tablet

No text provided. Please provide the text you want me to rephrase.

Uses of Sitawow M 50/500 Tablet

Managing type 2 diabetes

Major Benefits of Sitawow M 50/500 Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the Sitawow M 50/500 Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

Common Side effects of Sitawow M 50/500 Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitawow M 50/500 Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the Sitawow M 50/500 Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with food.

How Sitawow M 50/500 Tablet works:

Sitawow M 50/500 tablets combine sitagliptin and metformin to manage blood glucose levels. Sitagliptin boosts insulin production by the pancreas, enhances insulin effectiveness, and reduces hepatic glucose output. Metformin, a biguanide, works by decreasing liver glucose production, slowing intestinal glucose absorption, and improving insulin sensitivity. This dual action leads to superior blood sugar regulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Sitawow M 50/500 Tablet with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Sitawow M 50/500 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against potential dangers prior to prescribing. Physician consultation is recommended.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Sitawow M 50/500 Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitawow M 50/500 Tablets cautiously, potentially requiring dosage modification. Consult a physician. Sitawow M 50/500 Tablets are contraindicated in patients with severe kidney disease. Regular kidney function monitoring is recommended during treatment.

LiverLiverUNSAFE

Individuals with liver conditions should likely avoid Sitawow M 50/500 Tablets due to potential safety concerns. A physician's consultation is recommended.

What if you forget to take Sitawow M 50/500 Tablet :

Should you forget a dose of Sitawow M 50/500 Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitawow M 50/500 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Sitawow M 50/500 Tablet

Sitawow M 50/500 Tablet combines sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood glucose control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged Sitawow M 50/500 Tablet use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia and neurological issues, including tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Sitawow M 50/500 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Sitawow M 50/500 Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Sitawow M 50/500 Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitagliptin/Metformin (Sitawow M 50/500) can cause lactic acidosis (MALA), a serious medical emergency resulting from excess blood lactic acid. This rare side effect is more likely in patients with kidney disease, older individuals, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Sitawow M 50/500 Tablet combines sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood glucose control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sitawow M 50/500 Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Sitawow M 50/500 Tablets are contraindicated in patients with known allergies to its ingredients or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitawow M 50/500 Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitawow M 50/500 (containing metformin) can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA). This rare side effect necessitates avoiding metformin in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea/vomiting, abdominal pain, and bradycardia. If experienced, discontinue Sitawow M 50/500 and seek immediate medical attention.
Prolonged Sitawow M 50/500 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia and neurological issues, including numbness, tingling in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container as directed on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitawow M 50/500 Tablet combines sitagliptin and metformin to treat type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sitawow M 50/500 Tablet may cause common side effects such as low blood sugar, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitawow M 50/500 Tablets are contraindicated in patients with known allergies to its components or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitawow M 50/500 Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin + Metformin (Sitawow M 50/500 Tablet) can cause lactic acidosis (MALA), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged Sitawow M 50/500 Tablet use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency may cause anemia and neurological issues, including numbness, tingling in the extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitawow M 50/500 Tablet
146